CFR Pharmaceuticals Jumps on Higher Target Price: Santiago Mover

CFR Pharmaceuticals SA, Chile’s largest drug developer, advanced to a two-week high after brokerage IM Trust SA raised its target price and said a takeover last year will bring higher-than-expected sales.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.